FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2535103699> ?p ?o ?g. }

• W2535103699 endingPage "346" @default.
• W2535103699 startingPage "339" @default.
• W2535103699 abstract "Background: The use of platelet-rich plasma (PRP) for the treatment of osteoarthritis (OA) has demonstrated mixed clinical outcomes in randomized controlled trials when compared with hyaluronic acid (HA), an accepted nonsurgical treatment for symptomatic OA. Biological analysis of PRP has demonstrated an anti-inflammatory effect on the intra-articular environment. Purpose: To compare the clinical and biological effects of an intra-articular injection of PRP with those of an intra-articular injection of HA in patients with mild to moderate knee OA. Study Design: Randomized controlled trial; Level of evidence, 1. Methods: A total of 111 patients with symptomatic unilateral knee OA received a series of either leukocyte-poor PRP or HA injections under ultrasound guidance. Clinical data were collected before treatment and at 4 time points across a 1-year period. Synovial fluid was also collected for analysis of proinflammatory and anti-inflammatory markers before treatment and at 12 and 24 weeks after treatment. Several measures were used to assess results: (1) Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain subscale; (2) International Knee Documentation Committee (IKDC) subjective knee evaluation, visual analog scale (VAS) for pain, and Lysholm knee score; and (3) difference in intra-articular biochemical marker concentrations. Results: There were 49 patients randomized to treatment with PRP and 50 randomized to treatment with HA. No difference was seen between the groups in the primary outcome measure (WOMAC pain score). In the secondary outcome measure, linear contrasts identified a significantly higher IKDC score in the PRP group compared with the HA group at 24 weeks (mean ± standard error [SE], 65.5 ± 3.6 vs 55.8 ± 3.8, respectively; P = .013) and at final follow-up (52 weeks) (57.6 ± 3.37 vs 46.6 ± 3.76, respectively; P = .003). Linear contrasts also identified a statistically lower VAS score in the PRP group versus the HA group at 24 weeks (mean ± SE, 34.6 ± 3.24 vs 48.6 ± 3.7, respectively; P = .0096) and 52 weeks (44 ± 4.6 vs 57.3 ± 3.8, respectively; P = .0039). An examination of fixed effects showed that patients with mild OA and a lower body mass index had a statistically significant improvement in outcomes. In the biochemical analysis, differences between groups approached significance for interleukin-1β (mean ± SE, 0.14 ± 0.05 pg/mL [PRP] vs 0.34 ± 0.16 pg/mL [HA]; P = .06) and tumor necrosis factor α (0.08 ± 0.01 pg/mL [PRP] vs 0.2 ± 0.18 pg/mL [HA]; P = .068) at 12-week follow-up. Conclusion: We found no difference between HA and PRP at any time point in the primary outcome measure: the patient-reported WOMAC pain score. Significant improvements were seen in other patient-reported outcome measures, with results favoring PRP over HA. Preceding a significant difference in subjective outcomes favoring PRP, there was a trend toward a decrease in 2 proinflammatory cytokines, which suggest that the anti-inflammatory properties of PRP may contribute to an improvement of symptoms. Registration: ClinicalTrials.gov (Identifier: NCT02588872)." @default.
• W2535103699 created "2016-10-28" @default.
• W2535103699 creator A5028121711 @default.
• W2535103699 creator A5028654023 @default.
• W2535103699 creator A5059515326 @default.
• W2535103699 creator A5064391561 @default.
• W2535103699 creator A5067157002 @default.
• W2535103699 date "2016-10-21" @default.
• W2535103699 modified "2023-10-10" @default.
• W2535103699 title "Hyaluronic Acid Versus Platelet-Rich Plasma: A Prospective, Double-Blind Randomized Controlled Trial Comparing Clinical Outcomes and Effects on Intra-articular Biology for the Treatment of Knee Osteoarthritis" @default.
• W2535103699 cites W1791650479 @default.
• W2535103699 cites W1981022368 @default.
• W2535103699 cites W1981688423 @default.
• W2535103699 cites W1983106010 @default.
• W2535103699 cites W2006050540 @default.
• W2535103699 cites W2009242989 @default.
• W2535103699 cites W2021423062 @default.
• W2535103699 cites W2038773696 @default.
• W2535103699 cites W2066496557 @default.
• W2535103699 cites W2105350898 @default.
• W2535103699 cites W2108946677 @default.
• W2535103699 cites W2109675827 @default.
• W2535103699 cites W2110032671 @default.
• W2535103699 cites W2111068863 @default.
• W2535103699 cites W2111664065 @default.
• W2535103699 cites W2125605937 @default.
• W2535103699 cites W2132844854 @default.
• W2535103699 cites W2139382287 @default.
• W2535103699 cites W2141157018 @default.
• W2535103699 cites W2143328793 @default.
• W2535103699 cites W2149781582 @default.
• W2535103699 cites W2151528581 @default.
• W2535103699 cites W2164434561 @default.
• W2535103699 cites W2167792025 @default.
• W2535103699 doi "https://doi.org/10.1177/0363546516665809" @default.
• W2535103699 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28146403" @default.
• W2535103699 hasPublicationYear "2016" @default.
• W2535103699 type Work @default.
• W2535103699 sameAs 2535103699 @default.
• W2535103699 citedByCount "242" @default.
• W2535103699 countsByYear W25351036992016 @default.
• W2535103699 countsByYear W25351036992017 @default.
• W2535103699 countsByYear W25351036992018 @default.
• W2535103699 countsByYear W25351036992019 @default.
• W2535103699 countsByYear W25351036992020 @default.
• W2535103699 countsByYear W25351036992021 @default.
• W2535103699 countsByYear W25351036992022 @default.
• W2535103699 countsByYear W25351036992023 @default.
• W2535103699 crossrefType "journal-article" @default.
• W2535103699 hasAuthorship W2535103699A5028121711 @default.
• W2535103699 hasAuthorship W2535103699A5028654023 @default.
• W2535103699 hasAuthorship W2535103699A5059515326 @default.
• W2535103699 hasAuthorship W2535103699A5064391561 @default.
• W2535103699 hasAuthorship W2535103699A5067157002 @default.
• W2535103699 hasConcept C105702510 @default.
• W2535103699 hasConcept C126322002 @default.
• W2535103699 hasConcept C141071460 @default.
• W2535103699 hasConcept C14184104 @default.
• W2535103699 hasConcept C142724271 @default.
• W2535103699 hasConcept C168563851 @default.
• W2535103699 hasConcept C1862650 @default.
• W2535103699 hasConcept C204787440 @default.
• W2535103699 hasConcept C2776164576 @default.
• W2535103699 hasConcept C2776268809 @default.
• W2535103699 hasConcept C2777529286 @default.
• W2535103699 hasConcept C2779279471 @default.
• W2535103699 hasConcept C2779286237 @default.
• W2535103699 hasConcept C2780076745 @default.
• W2535103699 hasConcept C535046627 @default.
• W2535103699 hasConcept C71924100 @default.
• W2535103699 hasConcept C89560881 @default.
• W2535103699 hasConceptScore W2535103699C105702510 @default.
• W2535103699 hasConceptScore W2535103699C126322002 @default.
• W2535103699 hasConceptScore W2535103699C141071460 @default.
• W2535103699 hasConceptScore W2535103699C14184104 @default.
• W2535103699 hasConceptScore W2535103699C142724271 @default.
• W2535103699 hasConceptScore W2535103699C168563851 @default.
• W2535103699 hasConceptScore W2535103699C1862650 @default.
• W2535103699 hasConceptScore W2535103699C204787440 @default.
• W2535103699 hasConceptScore W2535103699C2776164576 @default.
• W2535103699 hasConceptScore W2535103699C2776268809 @default.
• W2535103699 hasConceptScore W2535103699C2777529286 @default.
• W2535103699 hasConceptScore W2535103699C2779279471 @default.
• W2535103699 hasConceptScore W2535103699C2779286237 @default.
• W2535103699 hasConceptScore W2535103699C2780076745 @default.
• W2535103699 hasConceptScore W2535103699C535046627 @default.
• W2535103699 hasConceptScore W2535103699C71924100 @default.
• W2535103699 hasConceptScore W2535103699C89560881 @default.
• W2535103699 hasIssue "2" @default.
• W2535103699 hasLocation W25351036991 @default.
• W2535103699 hasLocation W25351036992 @default.
• W2535103699 hasOpenAccess W2535103699 @default.
• W2535103699 hasPrimaryLocation W25351036991 @default.
• W2535103699 hasRelatedWork W2463317312 @default.
• W2535103699 hasRelatedWork W2535103699 @default.
• W2535103699 hasRelatedWork W2582002924 @default.
• W2535103699 hasRelatedWork W2884879194 @default.
• W2535103699 hasRelatedWork W3015818258 @default.

• next